Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

38.45USD
23 Sep 2016
Change (% chg)

$-0.33 (-0.85%)
Prev Close
$38.78
Open
$39.30
Day's High
$39.30
Day's Low
$38.32
Volume
681,555
Avg. Vol
789,435
52-wk High
$41.64
52-wk Low
$31.85

HOLX.OQ

Chart for HOLX.OQ

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics products include its Aptima family of assays,... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $10,666.91
Shares Outstanding(Mil.): 277.42
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): 41.99 46.41 36.60
EPS (TTM): 0.92 -- --
ROI: 3.95 7.61 13.91
ROE: 12.32 9.74 14.82

BRIEF-FDA expands emergency use authorization for Hologic's Aptima Zika virus assay

* FDA expands emergency use authorization for Hologic's Aptima Zika virus assay to include use with urine samples

Sep 08 2016

BRIEF-U.S. HHS awards $4.1 mln to Hologic to develop better Zika blood screening test

Aug 9 U.S. Department of Health and Human Services:

Aug 09 2016

BRIEF-Bovie Medical announces deal with Hologic Inc

* Bovie medical announces sales channel partnership agreement with hologic for J-Plasma

Jul 21 2016

BRIEF-Hologic, Grifols say FDA approves Zika diagnostic test

* FDA has approved use of Procleix Zika virus blood screening assay on Procleix panther system under agency's investigational new drug study protocol

Jun 20 2016

Hologic wins emergency U.S. authorization for Zika test

Hologic Inc won emergency U.S. authorization to sell its Zika test, expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections.

Jun 17 2016

Hologic wins emergency U.S. authorization for Zika test

Hologic Inc won emergency U.S. authorization to sell its Zika test, expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections.

Jun 17 2016

Hologic wins emergency U.S. authorization for Zika test

June 17 Hologic Inc won emergency U.S. authorization to sell its Zika test, expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections.

Jun 17 2016

BRIEF-Carl Icahn dissolves shared share stake in Hologic Inc

* Carl Icahn holdings cited is Icahn's shared share stake in the respective companies Source text for quarter ended March 31, 2016: (http://1.usa.gov/1OxDwCP) Source text for quarter ended Dec 31, 2015: (http://1.usa.gov/1TgSRoa) (Bengaluru Newsroom; +1 646 223 8780; )

May 16 2016

Father of ex-investment banker avoids prison for insider trading

The father of a former investment banker at Perella Weinberg Partners and JPMorgan Chase & Co was sentenced on Wednesday to a year of home confinement and three more years of probation, for trading securities ahead of healthcare mergers based on tips from his son.

May 04 2016

Father of ex-investment banker avoids prison for insider trading

The father of a former investment banker at Perella Weinberg Partners and JPMorgan Chase & Co was sentenced on Wednesday to a year of home confinement and three more years of probation, for trading securities ahead of healthcare mergers based on tips from his son.

May 04 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.